Compounded vs Brand-Name Semaglutide: Price, Safety, and Legality
Compare compounded semaglutide ($150-500/mo) vs brand-name Ozempic/Wegovy ($1,000+/mo). Is compounded semaglutide safe, legal, and effective?
| Dimension | semaglutide | semaglutide | Notes |
|---|---|---|---|
| Cost | $1,000-1,350/mo | $150-500/mo | Compounded semaglutide is 60-85% cheaper. Price varies by pharmacy and source. |
| FDA Oversight | Full FDA approval | 503A/503B compounding | Brand-name is fully FDA-regulated. Compounded is legal under FDA shortage rules but less regulated. |
| Purity/Testing | Pharmaceutical grade | Varies by pharmacy | Brand-name guaranteed pure. Compounded quality depends on the pharmacy — 503B facilities have stricter standards. |
| Availability | Supply shortages | Generally available | Brand-name semaglutide has had persistent shortages. Compounding pharmacies fill the gap. |
| Insurance | Sometimes covered | Rarely covered | Brand-name may be covered by insurance. Compounded is typically cash-pay only. |
| Legal Status | Standard Rx | Legal during shortage | Compounded semaglutide is legal while FDA shortage designation is active. Status may change. |
Learn more about each peptide
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss effects in clinical trials. It is sold under the brand names Ozempic (diabetes) and Wegovy (weight management).
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss effects in clinical trials. It is sold under the brand names Ozempic (diabetes) and Wegovy (weight management).
More comparisons
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.
Reviewed by Fat Man in the Arena · Updated March 2026
Medical Disclaimer: This comparison is for informational purposes only. Individual responses vary. Always consult a qualified healthcare provider before starting any peptide protocol.